Abstract:Background: Allergic Rhinitis (AR) is a prevalent chronic inflammatory nasal condition with significant negative effects on the patients' quality of life. This study aimed to investigate the efficacy of Montelukast and intranasal antihistamine in combination with intranasal corticosteroid (INCS) in moderate to severe allergic rhinitis on the patients' quality of life and AR control. Method: This double-blind randomized clinical trial study was carried out on 66 moderate to severe AR patients referred to Namazi Hospital, Shiraz, Iran from 2020 to 2021, who were randomly divided into 3 groups. Group one received Montelukast add-on therapy and Budesonide nasal spray. The second group received intranasal antihistamine (Azelastine) add-on therapy and Budesonide nasal spray and the third group as the control group received intranasal Budesonide spray with a placebo tablet.To measure the impact of each medication on the patient's quality of life and AR control, we employed the Sino-Nasal Outcome Test-22 questionnaire (SNOT 22). We evaluated the symptoms and compared them at baseline, one and three months after the start of treatments. Spirometry was performed to investigate the possibility of co-morbid asthma at baseline and end of the study. Results: The patients' mean age was 30.13 ± 12.7 years. Most patients experienced perennial AR (65.2%). Reduction of mean scores SNOT22 was statistically different between groups (P-value < 0.001). Three months after treatment, the mean decrease of SNOT-22 in the Azelastine group was statistically significant compared to both Montelukast (P-value < 0.001) and control groups (P-value < 0.001). No significant difference was observed between the Montelukast and control groups (P-value = 0.142). 23 of 66 patients were diagnosed with asthma and asthma treatment was initiated. The amount of FEV1 change after AR treatment was not statistically significant between the groups in asthmatic patients (P-value = 0.351). Conclusion: Based on our findings, we recommend Azelastine in conjunction with an intranasal corticosteroid for the treatment of moderate to severe allergic rhinitis. In moderate to severe AR or even asthma management, Montelukast has no greater impact than INCS.

Effects of montelukast in asthma patients combined with allergic rhinitis:meta-analysis

Efficacy and safety of Montelukast-Levocetirizine Combination Therapy in Combined Allergic Rhinitis and Asthma Syndrome: A Systematic Review and Meta-Analysis

Effect of montelukast on the apoptosis of eosinophil in bronchoalveloar lavage fluid

Changes of Eosinophils in Bronchoalveolar Lavage Fluid of Asthma in Children and the Modulation Effect of Montelukast

A Systematic Review and Meta-Analysis of Loratadine Combined with Montelukast for the Treatment of Allergic Rhinitis

The Efficacy of Montelukast Combined with Budesonide in Asthma Patients and the Combination’s Effects on the Patients’ Immune and Pulmonary Functions

Effects of oral montelukast on pulmonary function and clinical symptoms in acute asthma exacerbations: a randomized, double-blind, placebo-controlled trial

Efficacy of add-on montelukast in nonasthmatic eosinophilic bronchitis: the additive effect on airway inflammation, cough and life quality.

The Efficacy of Montelukast on the Airway Hyperresponsiveness in Children with Asthmatic Bron-chitis

A Comparative Study of Montelukast and Azelastine add on Therapy in Moderate to Severe Allergic Rhinitis Treatment: A Double-Blind Randomized Clinical Trial

Efficacy of Add-on Montelukast in Nonasthmatic Eosinophilic Bronchitis

Effect of leukotriene receptor antagonist on anti-inflammation and immune func-tion in asthmatic patients

Efficacy and Safety of Montelukast in Treatment of Acute Asthma in Adults:A Systematic Review

Effect of long time oral montelukast on pulmonary function and allergy index of patients with slight and moderate asthma

Efficacy of montelukast sodium chewable tablets combined with inhaled budesonide in treating pediatric asthma and its effect on inflammatory factors.

Randomized Controlled Clinical Trial Comparing Budesonide Plus Montelukast and Loratadine Plus Montelukast for Treatment of Moderate and Severe Persistent Allergic Rhinitis

A Meta-analysis of salmeterol fluticasone combined with montelukast in the treatment of asthma in children

Effect of montelukast and dexamethasone on inflammation of asthma

Meta Analysis Of the Efficacity and Security of Montelukast Combining with Budesonide Curing Asthma in Children

Clinical observation of montelukast combined with antibiotics in the treatment of bronchiectasis

Combining montelukast with exercise in the clinical treatment of children with mild asthma